major insurance changes are coming to glp 1 drugs glp-1 patient assistance program 🩺 WHAT IS THE GLP-1 BRIDGE PROGRAM? With new Medicare and rising interest in GLP-1 medications, many people wondering: “Do I qualify for help?” Some GLP-1 insurance change impacts millions

Overdosing on empagliflozin can lead to its side effects, such as dehydration or ketoacidosis becoming more pronounced

,

GLP-1 receptor agonists such as liraglutide, semaglutide, and dulaglutide have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, primarily in people with established cardiovascular disease or high cardiovascular risk

The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells

Itoh, K., et al., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements